Baku, Azerbaijan, Feb. 10
By Khalid Kazimov - Trend:
Iran has unveiled an enhanced version of centrifuges used in the production of recombinant drugs at the pharmaceutical research center Pasteur Institute, Fars news agency reported on Feb. 10.
The country's nuclear scientists made the centrifuges needed for the production of all biological products in the field of biotechnology.
Pasteur Managing Director Mostafa Qanei in an interview said that the new centrifuge is an enhancement of an older domestically made version that the center used for the production of recombinant drugs and vaccines.
He added that the new version has improved shortcomings with the old one, including lack of control systems to define a desirable temperature, rotation speed, acceleration, and vibration.
"But Western countries do not let Iran have the device by claiming that it could have double applications. Acquiring the machine from abroad would be a very complicated process and they would not give us some of the parts needed," he said.
Western countries have imposed sanctions on Iran claiming that the country is trying to use the nuclear energy for non-peaceful purposes, something Iran denies.
The sanctions have affected the country's health system both in terms of drugs import and equipment and technology needed in pharmaceutical centers. Under such circumstances, the Iranian government has decided to tap domestic talents to cope with the shortage of drugs and equipment.
Edited by CN